Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas-Reference-Cited by-同舟云学术

Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas

Published:2018-04-24 Issue:4 Volume:181 Page:495-504
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Olszewski Adam J.¹²^ORCID,Ollila Thomas¹²,Reagan John L.¹²^ORCID

Affiliation:

1. Department of Medicine; Alpert Medical School of Brown University; Providence RI USA

2. Division of Hematology and Oncology; Rhode Island Hospital; Providence RI USA

Funder

American Cancer Society

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15224/fullpdf

Reference40 articles.

1. Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries;Augustin;Journal of Cancer Research and Clinical Oncology,2017

2. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab;Barrans;Journal of Clinical Oncology,2010

3. Using the national cancer database for outcomes research: a review;Boffa;JAMA Oncology,2017

4. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the surveillance, epidemiology, and end results database;Castillo;Cancer,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Diagnostic Yield and Safety Profile of Ultrasound-Guided Lung Biopsies: A Cross-Sectional Study;Cancers;2024-08-16

2. The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration;Clinical Lymphoma Myeloma and Leukemia;2023-11

3. Factors associated with unresponsiveness to treatment in patients with non-Hodgkin lymphoma: 10 years of experience from a single center;Acta Medica Alanya;2023-06-21

4. RNA-seq analysis reveals candidate genes associated with proliferation, invasion, and migration in BCL11A knockdown B-NHL cell lines;Annals of Hematology;2023-05-06

5. A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra‐high‐risk patient with diffuse large B‐cell lymphoma;Internal Medicine Journal;2023-05-05